205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.83%
Net income growth under 50% of AVGO's 25.65%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
2.43%
Some D&A expansion while AVGO is negative at -0.07%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
1300.00%
Some yoy growth while AVGO is negative at -146.33%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-27.54%
Both cut yoy SBC, with AVGO at -0.94%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
336.76%
Slight usage while AVGO is negative at -41.98%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-785.71%
AR is negative yoy while AVGO is 80.19%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-132.50%
Both reduce yoy inventory, with AVGO at -200.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
305.88%
AP growth well above AVGO's 368.97%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
339.29%
Some yoy usage while AVGO is negative at -120.24%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
108.77%
Some yoy increase while AVGO is negative at -55.56%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
14.47%
Some CFO growth while AVGO is negative at -0.78%. John Neff would note a short-term liquidity lead over the competitor.
-25.91%
Negative yoy CapEx while AVGO is 8.73%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
25.91%
Acquisition growth of 25.91% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
13.27%
Purchases growth of 13.27% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-46.44%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-34.57%
Both yoy lines negative, with AVGO at -87.50%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-796.06%
We reduce yoy invests while AVGO stands at 62.70%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
38.89%
We slightly raise equity while AVGO is negative at -90.14%. John Neff sees competitor possibly preserving share count or buying back shares.
4.79%
Buyback growth below 50% of AVGO's 24.73%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.